Also trades as: BTMDW (OTC)
BTMD NASDAQ
biote Corp.
1W: -11.1%
1M: +25.1%
3M: -1.3%
YTD: -9.3%
1Y: -48.1%
3Y: -69.8%
5Y: -77.0%
$2.24
-0.09 (-3.86%)
Weekly Expected Move ±12.8%
$2
$2
$2
$3
$3
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
0
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$98.8M
52W Range1.27-4.75
Volume63,069
Avg Volume280,840
Beta1.66
Dividend—
Analyst Ratings
Company Info
CEORobert C. Peterson
Employees223
SectorHealthcare
IndustryMedical - Care Facilities
IPO Date2021-04-28
Websitebiote.com
1875 West Walnut Hill Lane
Irving, TX 75038
US
Irving, TX 75038
US
844-604-1246
About biote Corp.
Biote Corp. is dedicated to supporting and developing medical practices that focus on hormone optimization. The company provides a comprehensive system for its Biote-certified healthcare professionals, enabling them to correct imbalances in patients' hormone, vitamin, and mineral levels. This includes authorizing the prescription of bioidentical hormone treatments and suggesting suitable dietary supplements. Furthermore, Biote offers its own line of branded nutritional supplements and supplies sterile kits for inserting hormone pellets for both male and female individuals. Founded in 2011, Biote Corp. is based in Irvine, Texas.
Latest News
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Peterson Robert Char | A-Award | 206,746 | $2.46 | 2026-06-12 |
| Christensen Bret | A-Award | 130,000 | $2.34 | 2026-06-08 |
| Beer Marc D | A-Award | 114,157 | $2.34 | 2026-06-08 |
| HEYER ANDREW R | A-Award | 130,000 | $2.20 | 2026-05-12 |
| HEYER ANDREW R | A-Award | 35,259 | — | 2026-05-12 |